iseases and Disorders

33

G. Fiedorowicz, J. A. Mills, A. Ruggle, et al., “Suicidal behavior

prodromal huntington disease,” Neurodegenerative Diseases, vol. 8,

p. 483–490, 2011.

J. Sadock and V. A. Sadock, “Kaplan and sadock’s comprehensive

xtbook of psychiatry,” 2017.

E. Anderson, E. van Duijn, D. Craufurd, et al., “Clinical manage-

ent of neuropsychiatric symptoms of huntington disease: Expert-based

nsensus guidelines on agitation, anxiety, apathy, psychosis and sleep

sorders,” Journal of Huntington’s Disease, vol. 7, pp. 355–366, 2018.

J. Hughes, S. E. Daniel, Y. Ben-Shlomo, et al., “The accuracy of

agnosis of parkinsonian syndromes in a specialist movement disorder

rvice,” Brain: a journal of neurology, vol. 125 Pt 4, pp. 861–70, 2002.

S. Paulsen, “Functional imaging in huntington’s disease,” Experimen-

l Neurology, vol. 216, pp. 272–277, 2009.

S. Ishihara, D. Oliveri, and E. J. Wild, “Neuropsychiatric comor-

dities in huntington’s and parkinson’s disease: A united states claims

tabase analysis,” Annals of Clinical and Translational Neurology,

l. 8, pp. 126–137, 2020.

. Groves, “The highly anxious individual presenting for huntington

sease-predictive genetic testing: the psychiatrist’s role in assessment

d counseling,” Handbook of clinical neurology, vol. 144, pp. 99–105,

17.

-B. R. Wahlin, “To know or not to know: a review of behaviour and

icidal ideation in preclinical huntington’s disease,” Patient education

nd counseling, vol. 65 3, pp. 279–87, 2007.

Goldstein, O. Nayshool, B. Nefussy, et al., “Optn 691_692insag is a

under mutation causing recessive als and increased risk in heterozy-

tes,” Neurology, vol. 86, pp. 446–453, 2016.

. H. Hastings and M. Goedert, “Circadian clocks and neurodegener-

ive diseases: time to aggregate?,” Current Opinion in Neurobiology,

l. 23, pp. 880–887, 2013.

M. Ahmed, R. E. A. Newcombe, A. J. Piper, et al., “Sleep disorders

d respiratory function in amyotrophic lateral sclerosis,” Sleep medicine

views, vol. 26, pp. 33–42, 2016.

Byrne, C. Walsh, C. Lynch, et al., “Rate of familial amyotrophic lat-

al sclerosis: a systematic review and meta-analysis,” Journal of Neu-

logy, Neurosurgery & Psychiatry, vol. 82, pp. 623–627, 2010.

. Agrawal and A. Biswas, “Molecular diagnostics of neurodegenerative

sorders,” Frontiers in Molecular Biosciences, vol. 2, 2015.